Kymera Therapeutics, Inc.KYMRNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Percentile
P0
Near historical low
vs 5Y Ago
-2.6x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$-232.89M-19.7%
2024$-194.50M-89.2%
2023$-102.83M+32.8%
2022$-153.09M-18.7%
2021$-128.95M-246.3%
2020$88.13M+392.2%
2019$17.91M+200.2%
2018$-17.86M-